MAY 27, 2026
ThermoSafe Expands U.S. Based VIP Manufacturing to Strengthen Cold Chain Supply Assurance for Life Sciences Customers

FOR IMMEDIATE RELEASE
ThermoSafe Expands U.S. Based VIP Manufacturing to Strengthen Cold Chain Supply Assurance for Life Sciences Customers
Expansion enhances supply continuity, responsiveness, and performance reliability for temperature-sensitive pharmaceutical and biotech shipments
(Arlington Height, IL). May 26, 2026. ThermoSafe, a global leader in temperature-controlled packaging technologies, today announced a significant expansion of its U.S. based manufacturing capabilities for Vacuum Insulated Panels (VIPs), a critical component in high-performance cold chain packaging for the life sciences industry.
The investment strengthens ThermoSafe’s ability to support pharmaceutical and biotech customers with greater supply assurance, faster responsiveness, and increased operational control as global sourcing pressures and supply chain risks continue to evolve.
VIP technology plays a vital role in protecting temperature-sensitive therapies, offering superior thermal performance compared to traditional insulation materials. As demand for high-performing, ready-to-deploy packaging solutions grows, so does the need for consistent supply, faster turnaround, and increased transparency.
By expanding VIP manufacturing in-house in the United States, ThermoSafe enables customers to mitigate risk across multiple dimensions, including supply disruption, extended lead times, and variability in product performance.
“Control has become one of the most valuable assets in today’s supply chain. By expanding our U.S.-based VIP manufacturing, we are giving pharma and biotech customers the ability to reduce dependency, respond faster to change, and operate with greater confidence in how their temperature-sensitive products are protected,” said Jim Lassiter, President & CEO of ThermoSafe.
The expansion supports several key customer priorities, including:
- Supply Continuity – Domestic manufacturing reduces reliance on overseas suppliers, improving availability and predictability
- Faster Response Times – Domestic production enables greater agility and shorter lead times
- Consistent Performance – Increased manufacturing control supports reliable, high-quality VIP performance
- Scalable Flexibility – VIP configurations support a broad range of packaging designs and shipment profiles
- Reduced Operational Risk – Greater visibility and process control help minimize the potential for temperature excursions and product loss.
ThermoSafe’s vertically integrated approach also enables close collaboration with customers across package design, qualification, and implementation – helping ensure solutions are aligned to real-world distribution conditions and operational requirements.
As the life sciences cold chain industry continues to evolve, ThermoSafe remains focused on delivering solutions that balance performance, sustainability, and operational ease, while helping customers protect both their products and the patients who depend on them.
About ThermoSafe
ThermoSafe is a leading global provider of temperature-assurance technologies for the safe, efficient, and sustainable transport of pharmaceuticals, biologics, vaccines, and other temperature-sensitive products. With manufacturing and service centers across the Americas, Europe, and Asia, and innovation driven by ISC LabsTM, ThermoSafe is vertically integrated packaging partner that delivers reusable, rental, recyclable and single-use bulk and parcel solutions. We deliver reliable cold chain solutions that safeguards product integrity and patient safety through all the last-miles. Because every degree mattersTM.
